Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study

被引:0
|
作者
Xuejie Zhang
Ruoyu Jia
Zhifang Zheng
Luhua Jiang
Yizhou Xu
Ashok Raj
Dong Sun
机构
[1] Affiliated Hospital of Xuzhou Medical University,Department of Nephrology
[2] Jintan Hospital,Affiliated Hospital of Jiangsu University, Department of Nephrology
[3] Jinling Hospital,National Clinical Research Center of Kidney Diseases
[4] Affiliated Hospital of Medical School,Department of Urology
[5] Nanjing University,Department of Internal Medicine and Diagnostics
[6] Affiliated Hospital of Xuzhou Medical University,undefined
[7] Xuzhou Medical University,undefined
关键词
Peritoneal dialysis (PD); Anemia; Hypoxia inducible factor-prolyl hydroxylase inhibitors (HIF-PHI); Iron metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan
    Mita, Eiji
    Liu, Lauren J.
    Shing, Danielle
    Force, Lindsey
    Aoki, Kouji
    Nakamoto, Daisuke
    Ishizaki, Akinobu
    Konishi, Hiroki
    Mizutani, Hajime
    Ng, Leslie J.
    [J]. INTERNAL MEDICINE, 2023, 62 (10) : 1405 - 1414
  • [32] A Real-World Study on the Effect of Imrecoxib for Patients with Axial Spondyloarthritis
    Zong, He-xiang
    Xu, Sheng-qian
    Wang, Jian-xiong
    Chu, Yi-ran
    Chen, Ke-ming
    Wang, Cong
    Tong, Wan-qiu
    Wang, Xi-le
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2755 - 2765
  • [33] A real-world analysis of roxadustat effectiveness and safety in managing renal anemia among patients on maintenance hemodialysis: An observational study
    Zhang, Yuan
    Chen, Minyue
    Tang, Lian
    Chen, Xiangfan
    Meng, Yajing
    Feng, Sujuan
    [J]. MEDICINE, 2024, 103 (31)
  • [34] Fatigue in incident peritoneal dialysis and mortality: A real-world side-by-side study in Brazil and the United States
    Guedes, Murilo
    Wallim, Liz
    Guetter, Camila R.
    Jiao, Yue
    Rigodon, Vladimir
    Mysayphonh, Chance
    Usvyat, Len A.
    Barretti, Pasqual
    Kotanko, Peter
    Larkin, John W.
    Maddux, Franklin W.
    Pecoits-Filho, Roberto
    de Moraes, Thyago Proenca
    [J]. PLOS ONE, 2022, 17 (06):
  • [35] DOLAVI study: real-world data (RWD) of dolutegravir plus lamivudine in naive HIV-1-infected patients (week 24)
    Hidalgo-Tenorio, C.
    Pasquau, J.
    Vinuesa, D.
    Ferra, S.
    Terron, A.
    SanJoaquin, I.
    Payeras, A.
    Martinez, O.
    Omar-Mohamed-Balgahata, M.
    De la Torre, J.
    Lopez-Lirola, A.
    Palomares, J.
    Blanco, J. R.
    Montero, M.
    Sequera, S.
    Garcia-Vallecillos, C.
    [J]. HIV MEDICINE, 2021, 22 : 130 - 131
  • [36] Effect of Renamezin upon attenuation of renal function decline in pre-dialysis chronic kidney disease patients: 24-week prospective observational cohort study
    Park, Hayne Cho
    Cho, AJin
    Kim, Do Hyoung
    Yun, Kyu-sang
    Kim, Juhee
    Lee, Eun Young
    Jo, Sang Kyung
    Lee, So-Young
    Han, Kum Hyun
    Chang, Yoon Kyung
    Oh, Dong-Jin
    Lee, Young-Ki
    [J]. PLOS ONE, 2021, 16 (06):
  • [37] Comparison of risk of peritoneal dialysis-associated peritonitis between roxadustat and recombinant human erythropoietin in peritoneal dialysis patients: a retrospective comparative cohort study
    Zhang, Wei
    Tan, Yanhong
    Ai, Jun
    Luo, Fuzhang
    Su, Xiaoyan
    Wu, Qimeng
    Su, Lijuan
    Pan, Jianyi
    Zheng, Qingkun
    Li, Bin
    Chen, Jiayi
    Luo, Qimei
    Chen, Jinzhong
    Dou, Xianrui
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022,
  • [38] Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide
    Kalantar-Zadeh, Kamyar
    Parameswaran, Vidhya
    Ficociello, Linda H.
    Anderson, Ludmila
    Ofsthun, Norma J.
    Kwoh, Christopher
    Mullon, Claudy
    Kossmann, Robert J.
    Coyne, Daniel W.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (03) : 153 - 161
  • [39] Adalimumab therapy in patients with psoriatic arthritis: 24-week results of a phase III study
    Mease, PJ
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Steinfeld, SED
    Choy, EHS
    Perdok, RJ
    Weinberg, TA
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4097 - 4097
  • [40] EFFICACY OF 24-WEEK MONOTHERAPY WITH ACARBOSE, GLIBENCLAMIDE, OR PLACEBO IN NIDDM PATIENTS - THE ESSEN STUDY
    HOFFMANN, J
    SPENGLER, M
    [J]. DIABETES CARE, 1994, 17 (06) : 561 - 566